GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor

被引:6
|
作者
Eroglu, Evren Caglar [1 ]
Gulec, Umran Kucukgoz [2 ]
Vardar, Mehmet Ali [2 ]
Paydas, Semra [3 ]
机构
[1] Alata Hort Res Inst, Mersin, Turkey
[2] Cukurova Univ, Med Fac, Dept Gynecol Oncol, Adana, Turkey
[3] Cukurova Univ, Med Fac, Dept Oncol, Adana, Turkey
关键词
metabolomics; biomarker; ovarian cancer; benign tumor; healthy control; GC-MS; OPLS-DA; BIOMARKER DISCOVERY; MASS-SPECTROMETRY; PROSTATE-CANCER; METABOLOMICS; DIAGNOSIS; URINE; SERUM; IDENTIFICATION; PLASMA;
D O I
10.1177/14690667221098520
中图分类号
O64 [物理化学(理论化学)、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号
070203 ; 070304 ; 081704 ; 1406 ;
摘要
The aim of this study is to identify urinary metabolomic profile of benign and malign ovarian tumors patients. Samples were analyzed using gas chromatography-mass spectrometry (GC-MS) and metabolomic tools to define biomarkers that cause differentiation between groups. 7 metabolites were found to be different in patients with ovarian cancer (OC) and benign tumors (BT). R2Y and Q2 values were found to be 0.670 and 0.459, respectively. L-tyrosine, glycine, stearic acid, turanose and L-threonine metabolites were defined as prominent biomarkers. The sensitivity of the model was calculated as 90.72% and the specificity as 82.09%. In the pathway analysis, glutathione metabolism, aminoacyl-tRNA biosynthesis, glycine serine and threonine metabolic pathway, primary bile acid biosynthesis pathways were found to be important. According to the t-test, 29 metabolites were found to be significant in urine samples of OC patients and healthy controls (HC). R2Y and Q2 values were found to be 0.8170 and 0.749, respectively. These results showed that the model has high compatibility and predictive power. Benzoic acid, L-threonine, L-pyroglutamic acid, creatinine and 3,4-dihydroxyphenylacetic acid metabolites were determined as prominent biomarkers. The sensitivity of the model was calculated as 93.81% and the specificity as 98.59%. Glycine serine and threonine metabolic pathway, glutathione metabolism and aminoacyl-tRNA biosynthesis pathways were determined important in OC patients and HC. The R2Y, Q2, sensitivity and specificity values in the urine samples of BT patients and HC were found to be 0.869, 0.794, 91.75, 97.01% and 97.18%, respectively. L-threonine, L-pyroglutamic acid, benzoic acid, creatinine and pentadecanol metabolites were determined as prominent biomarkers. Valine, leucine and isoleucine biosynthesis and aminoacyl-tRNA biosynthesis were significant. In this study, thanks to the untargeted metabolomic approach and chemometric methods, every group was differentiated from the others and prominent biomarkers were determined.
引用
收藏
页码:12 / 24
页数:13
相关论文
共 50 条
  • [41] GC-MS Based Metabolite Profiling of Rice Koji Fermentation by Various Fungi
    Kim, Ah Jin
    Choi, Jung Nam
    Kim, Jiyoung
    Park, Sait Byul
    Yeo, Soo Hwan
    Choi, Ji Ho
    Lee, Choong Hwan
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (11) : 2267 - 2272
  • [42] Characterizing bourbon whiskey via the combination of LC-MS and GC-MS based molecular fingerprinting
    Xu, Rui
    Chen, Li
    Zhang, Huan
    Crowder, Michael W.
    Zhu, Jiangjiang
    FOOD CHEMISTRY, 2023, 423
  • [43] Survival differences exist between ovarian carcinosarcoma and serous ovarian carcinoma
    Sarangi, Shikha
    Langstraat, Carrie
    Martin, Janice
    Weaver, Amy
    McGree, Michaela
    Kumar, Sanjeev
    Bakkum-Gamez, Jamie
    GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 275 - 276
  • [44] Use of GC-MS based metabolic fingerprinting for fast exploration of fungicide modes of action
    Hu, Zhihong
    Dai, Tan
    Li, Lei
    Liu, Pengfei
    Liu, Xili
    BMC MICROBIOLOGY, 2019, 19 (1)
  • [45] Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma
    Hogg, Russell
    Scurry, James
    Kim, Soo-Nyung
    Friedlander, Michael
    Hacker, Neville
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 44 - 51
  • [46] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [47] Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma
    Chui, Michael Herman
    Xing, Deyin
    Zeppernick, Felix
    Wang, Zoe Q.
    Hannibal, Charlotte G.
    Frederiksen, Kirsten
    Kjaer, Susanne K.
    Cope, Leslie
    Kurman, Robert J.
    Shih, Ie-Ming
    Wang, Tian-Li
    Vang, Russell
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (11) : 1462 - 1472
  • [48] Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor
    Imamura, Hiroko
    Ohishi, Yoshihiro
    Aman, Murasaki
    Shida, Kaai
    Shinozaki, Tomoko
    Yasutake, Nobuko
    Sonoda, Keno
    Kato, Kiyoko
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2015, 46 (10) : 1455 - 1463
  • [49] The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor
    Katsakhyan, Levon
    Baraban, Ezra G.
    Dumoff, Kimberly L.
    Burger, Robert A.
    Parikh, Rupal
    Cooper, Kumarasen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (02) : 175 - 179
  • [50] IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA
    Park, Junsik
    Kim, Jung Chul
    Lee, Mi-Ran
    Lee, Joohyang
    Kim, Sunghoon
    Kim, Sang Wun
    Lee, Jung-Yun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A28 - A29